What is the appropriate workup and management for a 46‑year‑old Polynesian woman with mild normocytic anemia (red blood cell count 3.7 million/µL, hemoglobin 11.8 g/dL, hematocrit 34.7 %, mean corpuscular volume 93.8 fL)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup and Management of Mild Normocytic Anemia in a 46-Year-Old Polynesian Woman

This patient requires a systematic evaluation starting with a reticulocyte count and comprehensive iron studies, because normocytic anemia can represent early iron deficiency, anemia of chronic disease, or a hypoproliferative bone marrow disorder—each demanding different management. 1

Initial Diagnostic Approach

First-Line Laboratory Tests

Order the following tests immediately to classify the anemia mechanism:

  • Absolute reticulocyte count (or reticulocyte index) – A low/normal count (<2.0) indicates impaired red cell production (nutritional deficiency, chronic disease, renal insufficiency, or marrow failure), while an elevated count (>2.0) points to hemolysis or acute blood loss 1, 2

  • Complete iron panel – Obtain serum ferritin, transferrin saturation (TSAT), serum iron, and total iron-binding capacity (TIBC) because early iron depletion often presents with normal MCV before microcytosis develops 1, 2

  • Inflammatory markers – Measure C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) to identify anemia of chronic disease, which can mimic normocytic anemia 1

  • Peripheral blood smear – Examine for hypochromic cells (suggesting evolving iron deficiency), schistocytes (hemolysis), or dysplastic features (marrow disorder) 1, 2

  • Red cell distribution width (RDW) – An elevated RDW (>14%) in normocytic anemia strongly suggests underlying iron deficiency or mixed nutritional deficiencies 1, 2

Interpretation of Iron Studies

Iron deficiency can present with normal MCV in early stages, making iron studies essential even when red cell indices appear normal:

Clinical Context Ferritin Threshold TSAT Threshold Interpretation
No inflammation (normal CRP) <30 µg/L <16% Confirms iron deficiency [1,2]
Inflammation present (elevated CRP) ≤100 µg/L <20% Iron deficiency despite inflammation [1,2]
Inflammation present >100 µg/L <20% Anemia of chronic disease [1]
  • In Polynesian populations, screen for alpha-thalassemia trait if MCV trends toward the lower end of normal (80–85 fL) with normal iron studies, as this is highly prevalent in Pacific Islander ancestry 2

Directed Investigation Based on Reticulocyte Count

If Reticulocyte Count is Low/Normal (<2.0)

This indicates a hypoproliferative anemia; proceed with:

  • Renal function assessment – Measure serum creatinine and estimated glomerular filtration rate (eGFR), because chronic kidney disease produces normocytic anemia via erythropoietin deficiency when GFR falls below 30 mL/min 1, 2

  • Vitamin B12 and folate levels – Combined deficiencies can neutralize MCV (iron deficiency lowers it, B12/folate deficiency raises it), resulting in a normal MCV but elevated RDW 1, 2

  • Thyroid-stimulating hormone (TSH) – Hypothyroidism is a reversible cause of normocytic anemia 2

  • Medication review – Identify bone marrow suppressants (NSAIDs, antibiotics, chemotherapy agents) that can cause hypoproliferative anemia 1

If Reticulocyte Count is Elevated (>2.0)

This indicates appropriate marrow response; evaluate for:

  • Hemolysis panel – Order lactate dehydrogenase (LDH), indirect bilirubin, haptoglobin, and direct antiglobulin (Coombs) test 1, 2, 3

  • Stool guaiac test – Screen for occult gastrointestinal bleeding 1, 2

Management Based on Etiology

Iron Deficiency Anemia (Even with Normal MCV)

If ferritin <30 µg/L or TSAT <16% (or ferritin ≤100 µg/L with inflammation):

  • Initiate oral iron supplementation – Ferrous sulfate 325 mg once to three times daily 2

  • Monitor hemoglobin response – A rise of ≥10 g/L within 2 weeks confirms iron deficiency 4, 2

  • Investigate the source of iron loss – In a 46-year-old woman, evaluate for heavy menstrual bleeding (most common cause in premenopausal women) and gastrointestinal blood loss 4, 2

  • Consider gastrointestinal evaluation – If menstrual losses do not fully explain the anemia or if iron supplementation fails, perform upper endoscopy with duodenal biopsies (to exclude celiac disease, present in 2–3% of iron deficiency cases) and colonoscopy 4, 2

Anemia of Chronic Disease

If ferritin >100 µg/L, TSAT <20%, and elevated CRP/ESR:

  • Treat the underlying inflammatory condition – Management focuses on controlling the primary disease (autoimmune disorder, chronic infection, inflammatory bowel disease) 1

  • Do not give iron supplementation – Iron is sequestered in macrophages and will not improve anemia; inappropriate iron may worsen outcomes 1

  • Monitor hemoglobin every 6 months – More frequent monitoring is needed during active inflammation 1

Chronic Kidney Disease

If serum creatinine ≥2 mg/dL with normocytic anemia and no other cause identified:

  • Erythropoietin deficiency is the likely primary etiology – Routine measurement of serum erythropoietin is not indicated 2

  • Do not initiate erythropoiesis-stimulating agents (ESAs) until hemoglobin falls below 10 g/dL in asymptomatic patients 1, 3

Critical Pitfalls to Avoid

  • Do not assume normocytic anemia excludes iron deficiency – Early iron depletion produces normocytic anemia because circulating red cells were made before iron stores became critically low; an elevated RDW (>14%) is the key clue 1, 2

  • Do not interpret ferritin without concurrent CRP measurement – Ferritin is an acute-phase reactant that can be falsely elevated by inflammation, infection, malignancy, or liver disease, masking true iron deficiency 1, 2

  • Do not overlook combined deficiencies – Iron deficiency can coexist with vitamin B12 or folate deficiency, producing a normal MCV but elevated RDW 1, 2

  • Do not delay investigation in Polynesian patients – Alpha-thalassemia trait is highly prevalent (28–55% of microcytic anemia cases in Southeast Asian populations) and should be considered if MCV trends low with normal iron studies 2

  • Do not give empiric iron therapy without confirming iron deficiency – In anemia of chronic disease or marrow failure syndromes, inappropriate iron may worsen outcomes 1

Transfusion Threshold

Transfuse packed red blood cells only if hemoglobin falls below 7–8 g/dL or the patient develops severe symptoms (chest pain, resting dyspnea, hemodynamic instability), regardless of the numeric hemoglobin value 1, 3

References

Guideline

Normocytic Anemia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Anemia Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Anemia: Normocytic Anemia.

FP essentials, 2023

Guideline

Management of Microcytic Hypochromic Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.